-
1 Comment
Anhui Huangshan Capsule Co., Ltd is currently in a long term uptrend where the price is trading 17.2% above its 200 day moving average.
From a valuation standpoint, the stock is 34.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.3.
Anhui Huangshan Capsule Co., Ltd's total revenue sank by 18.8% to $72M since the same quarter in the previous year.
Its net income has increased by 85.3% to $14M since the same quarter in the previous year.
Finally, its free cash flow grew by 37.5% to $16M since the same quarter in the previous year.
Based on the above factors, Anhui Huangshan Capsule Co., Ltd gets an overall score of 4/5.
| CurrencyCode | CNY |
|---|---|
| Sector | Healthcare |
| Exchange | SHE |
| ISIN | CNE100002BV5 |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | 40.12 |
|---|---|
| Target Price | None |
| Dividend Yield | 1.7% |
| Beta | 0.33 |
| Market Cap | 2B |
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. It offers hypromellose empty capsules, pullulan empty capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose capsules, and hydroxypropyl starch hollow capsules. The company was founded in 1989 and is headquartered in Xuancheng, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002817.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
